Research and Development

In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …

The Medical Research Council has appointed Sir John Savill as chief executive and deputy chair with effect from 1 October. …

Irish drugmaker Elan has postponed plans to separate its business into two publicly-listed companies due to adverse market conditions. Elan …

Clinical services company ACM Global has made several new appointments at its UK and US facilities. Its Global Central Laboratory …

Dr Neill Moray Mackenzie has joined Hertfordshire, UK-based biopharmaceutical company CMP Therapeutics as chief executive. He has a long record …

 This article was originally published by PharmaPhorum in Spring 2010.  

Daiichi Sankyo and biotech firm Arqule are to move their lung cancer treatment ARQ 197 into phase III trials. The …

Pharmaceutical services company Quintiles has named Kevin Gordon chief financial officer. He will have day-to-day responsibility for the company’s financial …

Shire has made a €428 million offer for Belgium-based Movetis in a bid to grow its business in Europe and …

Charles River Laboratories has terminated its $1.6 billion agreement to acquire Chinese contract research organisation WuXi PharmaTech after an investor …

Anne-Marie Masquelier has joined healthcare research company Cegedim Strategic Data as global medical research director. She will be responsible for …

Electronic data capture (EDC) has become the norm for clinical studies. In an EDC study, most of the deliverables are …

Sanofi-Aventis UK has appointed Dr Ian Weatherhead as its director of communications. Ian will join the Guildford-based company in October, …

PharmaNet Development Group has appointed Dr Wolfgang Renz senior vice president of clinical operations. He will be responsible for the …

Karen Lackey has been appointed vice-president and head of medicinal chemistry by Roche. She will be based at the company’s …